131 results
Page 2 of 7
8-K
EX-99.1
jbiyc7plzaerjn e80
12 May 23
Adaptimmune Reports First Quarter Financial Results and Business Update
7:36am
424B3
jbaefq45o 3n4cc
20 Apr 23
Prospectus supplement
4:32pm
S-4/A
k3omhqfzbfb
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
S-4
64wjf32e
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-99.1
vkw z3fpcif6r1s
25 Oct 22
Adaptimmune Enhances its Pipeline of Wholly Owned Cell Therapies for Cancer with Transfer of PRAME and NY-ESO Target Programs from GSK
8:10am
8-K
ski23o
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
8-K
EX-10.1
x4dakz3
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
8-K
EX-10.01
p6t2n2t
26 Jan 22
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
8:05am